312 related articles for article (PubMed ID: 19422858)
1. TGF-beta1 and TGF-beta2 strongly enhance the secretion of plasminogen activator inhibitor-1 and matrix metalloproteinase-9 of the human prostate cancer cell line PC-3.
Konrad L; Scheiber JA; Schwarz L; Schrader AJ; Hofmann R
Regul Pept; 2009 Jun; 155(1-3):28-32. PubMed ID: 19422858
[TBL] [Abstract][Full Text] [Related]
2. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
3. Studies of TGF-beta(1-3) in serosal fluid during abdominal surgery and their effect on in vitro human mesothelial cell proliferation.
Falk P; Bergström M; Palmgren I; Holmdahl L; Breimer ME; Ivarsson ML
J Surg Res; 2009 Jun; 154(2):312-6. PubMed ID: 19062040
[TBL] [Abstract][Full Text] [Related]
4. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene.
Hageman J; Eggen BJ; Rozema T; Damman K; Kampinga HH; Coppes RP
Clin Cancer Res; 2005 Aug; 11(16):5956-64. PubMed ID: 16115939
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway.
Tian YC; Chen YC; Chang CT; Hung CC; Wu MS; Phillips A; Yang CW
Exp Cell Res; 2007 Jul; 313(11):2367-77. PubMed ID: 17467690
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
Kawada M; Inoue H; Arakawa M; Ikeda D
Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013
[TBL] [Abstract][Full Text] [Related]
7. The effect of TGF-beta2 on MMP-2 production and activity in highly metastatic human bladder carcinoma cell line 5637.
Dehnavi E; Soheili ZS; Samiei S; Ataei Z; Aryan H
Cancer Invest; 2009 Jun; 27(5):568-74. PubMed ID: 19219652
[TBL] [Abstract][Full Text] [Related]
8. [Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells].
Zhang JJ; Wang B
Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):194-7. PubMed ID: 16640888
[TBL] [Abstract][Full Text] [Related]
9. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells.
Konrad L; Scheiber JA; Völck-Badouin E; Keilani MM; Laible L; Brandt H; Schmidt A; Aumüller G; Hofmann R
BMC Genomics; 2007 Sep; 8():318. PubMed ID: 17845732
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
[TBL] [Abstract][Full Text] [Related]
12. Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system.
Lin SW; Ke FC; Hsiao PW; Lee PP; Lee MT; Hwang JJ
Exp Cell Res; 2007 Feb; 313(3):602-13. PubMed ID: 17187779
[TBL] [Abstract][Full Text] [Related]
13. Effect of 17beta-estradiol on apoptosis, IGF system components and gelatinases A and B in prostate cancer cells (PC-3).
Kanagaraj P; Vijayababu MR; Ilangovan R; Senthilkumar K; Venkataraman P; Aruldhas MM; Arunakaran J
Clin Chim Acta; 2007 Feb; 377(1-2):70-8. PubMed ID: 17083925
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
Sehgal I; Baley PA; Thompson TC
Cancer Res; 1996 Jul; 56(14):3359-65. PubMed ID: 8764134
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal effects of ascorbate on cancer cell growth and the expression of matrix metalloproteinases and transforming growth factor-beta.
Philips N; Keller T; Holmes C
Cancer Lett; 2007 Oct; 256(1):49-55. PubMed ID: 17602832
[TBL] [Abstract][Full Text] [Related]
16. Growth factor regulation of secreted matrix metalloproteinase and plasminogen activators in prostate cancer cells, normal prostate fibroblasts and normal osteoblasts.
Forbes K; Webb MA; Sehgal I
Prostate Cancer Prostatic Dis; 2003; 6(2):148-53. PubMed ID: 12806374
[TBL] [Abstract][Full Text] [Related]
17. Effect of TGF-β on ocular surface epithelial cells.
Benito MJ; Calder V; Corrales RM; García-Vázquez C; Narayanan S; Herreras JM; Stern ME; Calonge M; Enríquez-de-Salamanca A
Exp Eye Res; 2013 Feb; 107():88-100. PubMed ID: 23220729
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 modulates metalloproteinase-2 and -9, nitric oxide, RhoA and alpha-smooth muscle actin expression in colon adenocarcinoma cells.
Paduch R; Kandefer-Szerszeń M; Szuster-Ciesielska A; Plewka K
Cell Biol Int; 2010 Jan; 34(2):213-23. PubMed ID: 19947919
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells.
Otsuka G; Stempien-Otero A; Frutkin AD; Dichek DA
Circ Res; 2007 May; 100(9):1300-7. PubMed ID: 17431190
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.
Clark-Greuel JN; Connolly JM; Sorichillo E; Narula NR; Rapoport HS; Mohler ER; Gorman JH; Gorman RC; Levy RJ
Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
